Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001104659-21-140226

Chief Financial Officer acquired 118,916 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Dalgleish Scott · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-12 Grant or award : show line 1 in the form +47,566 47,566 D
2021-11-12 Grant or award : show line 2 in the form +71,350 118,916 D

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-11-12 Grant or award : show line 3 in the form Stock Options (right to buy) +261,023 261,023 D
2021-11-12 Grant or award : show line 4 in the form Stock Options (right to buy) +350,876 350,876 D
Loading xslF345X03/tm2132979d17_4seq1.xml…